Hormonal
High consumption of sugar-sweetened beverages (SSBs) causes an increased risk of coronary heart disease (CHD) and type 2 diabetes, independent of body mass index (BMI).
Stop drinking sugar-sweetened beverages. Even if you maintain your weight, the sugar in these drinks independently raises your risk of heart disease and type 2 diabetes. Choose water, unsweetened tea, or coffee instead.
In addition to the effect of sugar-sweetened beverages (SSBs) on adiposity (body mass index, BMI), evidence from prospective studies suggested an additional, BMI-independent effect of SSBs on incidence of type 2 diabetes and coronary heart disease (CHD).
Why this rating
The paper classifies the evidence for SSBs and diabetes/CHD as 'probable or convincing' based on Bradford-Hill criteria.
Source
Etiologic effects and optimal intakes of foods and nutrients for risk of cardiovascular diseases and diabetes: Systematic reviews and meta-analyses from the Nutrition and Chronic Diseases Expert Group (NutriCoDE)
Renata Micha et al. · PLoS ONE · 2017
DOI 10.1371/journal.pone.0175149
More from this paper
- High consumption of dietary sodium increases systolic blood pressure (SBP) and the risk of fatal cardiovascular disease (CVD).Strong
- High consumption of trans-fats causes an increased risk of coronary heart disease (CHD).Strong
- High consumption of processed meats causes an increased risk of fatal coronary heart disease (CHD).Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →